IDEXX Laboratories Inc IDXX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$9.30M (8 inflow days, 12 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 31.0% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 2.46% to 2.99% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q4 | +915,772 | 1.7% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q4 | +498,245 | 1.4% |
| Millennium Management LLC | Hedge Fund | 2026/Q4 | +326,655 | 0.6% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q4 | +292,353 | 1.7% |
| UBS Asset Management | Mutual Fund | 2026/Q4 | +214,661 | 1.9% |
| Jupiter Fund Management Plc | Mutual Fund | 2026/Q4 | +214,081 | 0.4% |
| Schroder Investment Management Limited | Mutual Fund | 2026/Q4 | +172,689 | 0.5% |
| Holocene Advisors, LP | Hedge Fund | 2026/Q4 | +158,297 | 0.4% |
| Los Angeles Capital Management LLC | Mutual Fund | 2026/Q4 | +132,860 | 0.2% |
| FMR | Mutual Fund | 2026/Q4 | +116,793 | 0.9% |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | Private Company | 2026/Q4 | +89,504 | 0.2% |
| Morgan Stanley | Public Company | 2026/Q4 | +84,681 | 0.7% |
| Artisan Partners Limited Partnership | Mutual Fund | 2026/Q4 | +80,073 | 0.1% |
| RBC Global Asset Management Inc. | Mutual Fund | 2026/Q4 | +78,968 | 0.2% |
| ING Groep N.V. | Public Company | 2026/Q4 | +73,685 | 0.1% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 9 Nov 2026 | George Fennell | Executive Vice President of Global CAG Commercial | Derivative Exercise and Retained | +1,749 | $206.94 | 12,182 |
| 3 Nov 2026 | Daniel Junius | Independent Director | Open Market Disposition | -1,200 | $705.78 | 2,361 |
| 3 Nov 2026 | Daniel Junius | Independent Director | Intent to Sell (Form 144) | -1,200 | $705.78 | – |
| 3 Nov 2026 | Sharon Underberg | Executive VP, General Counsel, & Corporate Secretary | Derivative Exercise and Sale | -8,906 | $690.02 | 7,169 |
| 3 Nov 2026 | Jonathan Mazelsky | Executive Chairperson | Derivative Exercise and Sale | -25,140 | $711.95 | 83,803 |
| 3 Nov 2026 | Michael Lane | Executive VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology | Open Market Disposition | -3,978 | $689.70 | 4,301 |
| 29 Oct 2026 | Joseph Hooley | Independent Director | Other Acquisition | +48 | $551.21 | 215 |
| 3 Sep 2026 | Lawrence Kingsley | Lead Independent Director | Derivative Exercise and Sale | -2,203 | $532.08 | 8,570 |
| 19 Aug 2026 | Andrew Emerson | Chief Financial Officer | Derivative Exercise and Sale | -86 | $178.26 | 4,356 |
| 19 Aug 2026 | Andrew Emerson | Chief Financial Officer | Derivative Exercise and Retained | +179 | $178.26 | 4,356 |
| 29 Jul 2026 | Joseph Hooley | Independent Director | Other Acquisition | +49 | $558.80 | 158 |
| 31 May 2026 | George Fennell | Executive Vice President of Global CAG Commercial | Derivative Exercise and Sale | -284 | $566.79 | 10,433 |
| 31 May 2026 | George Fennell | Executive Vice President of Global CAG Commercial | Derivative Exercise and Retained | +355 | – | 10,433 |
| 11 May 2026 | Daniel Junius | Independent Director | Other Derivative Acquisition | +234 | – | 234 |
| 11 May 2026 | Daniel Junius | Independent Director | Other Derivative Acquisition | +525 | $533.92 | 525 |
| 11 May 2026 | Bruce Claflin | Independent Director | Other Derivative Acquisition | +234 | – | 1,354 |
| 11 May 2026 | Bruce Claflin | Independent Director | Other Derivative Acquisition | +525 | $533.92 | 525 |
| 11 May 2026 | Stuart Essig | Independent Director | Other Derivative Acquisition | +234 | – | 234 |
| 11 May 2026 | Stuart Essig | Independent Director | Other Derivative Acquisition | +525 | $533.92 | 525 |
| 11 May 2026 | Joseph Hooley | Independent Director | Other Derivative Acquisition | +234 | – | 234 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 2,354,117 | 3.0% | 4.5 |
| 15 Oct 2026 | 1,929,268 | 2.4% | 3.6 |
| 30 Sep 2026 | 1,940,639 | 2.5% | 3.9 |
| 15 Sep 2026 | 1,917,016 | 2.4% | 3.8 |
| 31 Aug 2026 | 2,092,080 | 2.7% | 4.4 |
| 14 Aug 2026 | 1,937,469 | 2.5% | 2.6 |
No comments yet — be the first to weigh in on IDXX.
Sign in to join the discussion.